Moody’s rates U.S. Renal Care notes Caa2

Moody's Investors Service said it assigned a Caa2 rating to U.S. Renal Care, Inc.'s new senior unsecured notes.

There is no change to the company's existing ratings, including the B3 corporate family rating, B3-PD probability of default rating, and B2 ratings on the company's new senior secured revolving credit facility and term loan.

The outlook is stable.

Moody's said it expects that the proceeds from these notes, along with the company's proposed credit facility and equity, will be used to finance the $2.7 billion leveraged buyout of the company by a consortium of private equity investors led by Bain Capital and Summit Partners.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.